Drugs / Cellentra™ VCBM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02182843 | Mar 2014 → Jan 2018 | cervical disk degenerative disorder | Zimmer Biomet | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellentra VCBM | “Cellentra™ VCBM is an allogenic bone graft containing naturally occurring viable donor cells intended for homologous use in the repair, replacement, reconstruction or...” NCT02182843 ↗ |
| Action | Restore | “intended for homologous use in the repair, replacement, reconstruction or supplementation of the recipient's tissue” NCT02182843 ↗ |